FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry and describes a peroral combined medication for the treatment of arterial hypertension in patients with diabetes mellitus. The medication is made in the form of a tablet. The combined tablet contains perindopril erbumine, amlodipine besylate, sorbitol, microcrystalline cellulose, sodium carboxymethyl starch, povidone, magnesium stearate in quantities, given in the invention formula.
EFFECT: combination of perindopril, amlodipine and sorbitol in the composition of one tablet provides enhancement of the therapeutic effect.
6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-HYPERTENSION ORGANIC SALT | 2009 |
|
RU2413717C2 |
| COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE | 2003 |
|
RU2336876C2 |
| HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CANAL BLOCKERS | 1999 |
|
RU2450813C2 |
| METHOD OF TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION OF 1 DEGREE IN PATIENTS IN EARLY PERIOD OF OLD AND SENILE AGE | 2019 |
|
RU2726071C1 |
| HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKING AGENT | 1999 |
|
RU2243768C2 |
| MEDICINAL AGENT FOR TREATMENT OF HYPERTENSION OR HIGH BLOOD PRESSURE | 2010 |
|
RU2539382C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING SELECTIVE AGONIST OF IMIDAZOLINE RECEPTOR I1 AND BLOCKER OF ANGIOTENSIN II RECEPTOR | 2004 |
|
RU2362561C2 |
| COMBINATION OF ORGANIC COMPOUNDS | 2003 |
|
RU2324482C2 |
| 6-METHYL-1-(1-OXOTHIETAN-3-YL)URACIL, HAVING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2536683C1 |
| MEDICINAL FORMULATION ELICITING VASODILATING, ANTI-ANGINAL, HYPOTENSIVE AND SPASMOLYTIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2239433C1 |
